Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens

CytoJournal

Volumn 9, Issue 1, 2012, Pages

  Sethi, Seema ^a   Geng, Lili ^a   Shidham, Vinod B ^a   Archuletta, Pamela ^a   Bandyophadhyay, Sudeshna ^a   Feng, Jining ^b   Madan, Shashi ^a   Shi, Dongping ^a   Tranchida, Paul ^a   Giorgadze, Tamar ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Adenocarcinoma; CK5; FNA; lung; Napsin A; p63; squamous cell carcinoma; TTF 1

Indexed keywords

CYTOKERATIN 5; FORMALDEHYDE; NAPSIN A; PARAFFIN; PROTEIN P63; PROTEINASE; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; CANCER TISSUE; CELL MEMBRANE; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPATHOLOGY; CYTOPLASM; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EMBEDDING; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG POORLY DIFFERENTIATED CARCINOMA; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; PREDICTIVE VALUE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SENSITIVITY AND SPECIFICITY; TISSUE DIFFERENTIATION; TISSUE SECTION; TUMOR CELL;

EID: 84865163171     PISSN: 09745963     EISSN: 17426413     Source Type: Journal    
DOI: 10.4103/1742-6413.94570     Document Type: Article

References (25)

1. Terry J, Leung S, Laskin J, Leslie KO, Gown AM, Ionescu DN. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am J Surg Pathol 2010;34:1805-11.
2. Fatima N, Cohen C, Siddiqui MT. DOG1 Utility in diagnosing gastrointestinal stromal tumors on fine-needle aspiration. Cancer Cytopathol 2011;119:202-8.
3. Cohen MH, Gootenberg J, Keegan P, Pazdur R. FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer. Oncologist 2007;12:713-8. (Pubitemid 47036205)
4. Herbst RS. Bevacizumab/chemotherapy in non-small-cell lung cancer: looking for a few good men? Clin Lung Cancer 2008;9:75-6. (Pubitemid 351631917)
5. Herbst RS. Toxicities of antiangiogenic therapy in non-small-cell lung cancer. Clin Lung Cancer 2006;8 Suppl 1:S23-30.
6. Sandler A. Bevacizumab in non small cell lung cancer. Clin Cancer Res 2007;13:s4613-6.
7. Hirsch FR, Spreafico A, Novello S, Wood MD, Simms L, Papotti M. The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review. J Thorac Oncol 2008;3:1468-81.
8. Shidham VB. Respiratory Cytology. In: Atkinson BF, editor. Atkinson Atlas of Diagnostic Cytopathology. 2 nd ed, Chapter 7. Philadelphia, PA: W. B. Saunders Company; 2004. p. 273-356.
9. Shidham VB, Kajdacsy-Balla AA. Immunohistochemistry: Diagnostic and Prognostic Applications. In Detrick B, Hamilton RG, Folds JD eds. Manual of Molecular and Clinical Laboratory Immunology. American Society of Microbiology Press. 7 th ed, Chapter 47, Year 2006, p408-413 ( http://online.statref.com/ titleinfo/fxid-274.html ).
10. Shidham VB, Atkinson BF. Immunocytochemistry of effusion fluids: Introduction to the SCIP approach. In: Shidham VB, Atkinson BF, editors. ′Cytopathologic Diagnosis of Serous Fluids, Chapter 5. Philadelphia, PA: Elsevier (W. B. Saunders Company); 2007. p. 55-78.
11. Stoll LM, Johnson MW, Gabrielson E, Askin F, Clark DP, Li QK. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas. Cancer Cytopathol 2010;118:441-9.
12. Lau SK, Luthringer DJ, Eisen RN. Thyroid transcription factor-1: a review. Appl Immunohistochem Mol Morphol 2002;10:97-102. (Pubitemid 34553163)
13. Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med 2008;132:384-96. (Pubitemid 351328813)
14. Yang M, Nonaka D. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol 2010;23:654-61.
15. Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol 2010;41:20-5.
16. Ueno T, Linder S, Na CL, Rice WR, Johansson J, Weaver TE. Processing of pulmonary surfactant protein B by napsin and cathepsin H. J Biol Chem 2004;279:16178-84. (Pubitemid 38509310)
17. Lin S, Na CL, Akinbi HT, Apsley KS, Whitsett JA, Weaver TE. Surfactant protein B (SP-B)-/-mice are rescued by restoration of SP-B expression in alveolar type II cells but not Clara cells. J Biol Chem 1999;274:19168-74.
18. Schultz H, Khler D, Branscheid D, Vollmer E, Zabel P, Goldmann T. TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens. Diagn Pathol 2008;3:35.
19. Kalhor N, Zander DS, Liu J. TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material. Mod Pathol 2006;19:1117-23. (Pubitemid 44106727)
20. Fatima N, Cohen C, Lawson D, Siddiqui MT. TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. Cancer Cytopathol. 2011 Apr 25;119(2):127-33. doi: 10.1002/cncy.20135.
21. Khayyata S, Yun S, Pasha T, Jian B, McGrath C, Yu G, et al. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens. Diagn Cytopathol 2009;37:178-83.
22. Fatima N, Cohen C, Lawson D, Siddiqui MT. TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. Cancer Cytopathol 2011;119:127-33.
23. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003;95:1276-99. (Pubitemid 37160862)
24. Varsegi GM, Shidham V. Cell block preparation from cytology specimen with predominance of individually scattered cells. J Vis Exp 2009;(29). pii: 1316. Available from: http://www.jove.com/index/Details.stp?ID=1316. [Last accessed on 2011 Oct 1].
25. Zhang H, Liu J, Cagle PT, Allen TC, Laga AC, Zander DS. Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach. Mod Pathol 2005;18:111-8. (Pubitemid 40128103)